A professor says that Indonesia needs to follow up on India's success in facilitating affordable prices for medicines and medical devices for public.

New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central ...

Inspired by the myriad of people trying out the 75 Hard Challenge on your social feed? It’s hard not to be, especially when you’re looking at those progress pics. But, what is 75 Hard ...

FRIDAY, Jan. 17, 2025 (HealthDay News) -- Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study recently published in the Journal ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

ABU DHABI, 6th June, 2017 (WAM) -- The UAE Ministry of Health and Prevention has issued a circular to all medical facilities and hospitals to withdraw Brilinta 90 mg batch number JB504 ... the ...

If you’re reading this and you have TikTok, I guarantee you’ll have heard of 75 Hard. The challenge has ... and the water intake was so generic; a 100kg individual would be drinking the ...

The approved dose of Niktimvo for adults and pediatric patients weighing at least 40 kg is 0.3 mg/kg, up to a maximum dose of 35 mg, as an intravenous infusion over 30 minutes every two weeks.

– Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drivers of inflammation and fibrosis – – Pivotal data from the AGAVE-201 trial ...

LONDON, Jan 15 (Reuters) - The chief executive of Airbus (AIR.PA), opens new tab said he was confident the company would reach its target of manufacturing 75 single-aisle aircraft a month in 2027 ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

The FTC’s findings—which analyzed 51 specialty generic drugs from 2017 to 2022—showed these pharmacy benefit managers’ (PBMs') affiliated pharmacies spun up $7.3 billion in excess revenue ...